ArticleCancer chemotherapy and pharmacology2025

Severe toxicity following genotype-guided reduced 5-FU dose in a heterozygous DPYD c.2846A>T carrier with stage III anal carcinoma: A case report.

Madeline L Norris et al.PubMed ↗Publisher ↗

No numbers read from the abstract.